Vergoeding 2019-2023 voor ATC-subgroep S01LA04 : Ranibizumab
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022* | 2023* | |
|---|---|---|---|---|---|
|
S01LA04 Ranibizumab
|
21.527.104 | 20.580.810 | 21.151.373 | 18.813.011 | 17.617.781 |
| Totaal | 21.527.104 | 20.580.810 | 21.151.373 | 18.813.011 | 17.617.781 |